Patent · US Active

Disubstituted benzothienyl-pyrrolotriazines and uses thereof

US9206184B2 · kind B2 · utility

2Cited by

0References

4Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Dirk Brohm · Mettmann, DE
Melanie HEROULT · Mülheim an der Ruhr, DE
Marie-Pierre Collin · Wuppertal, DE
Walter Hubsch · Wuppertal, DE
Mario Lobell · Wuppertal, DE
Klemens Lustig · Wuppertal, DE
Sylvia Grünewald · Berlin, DE
Ulf Bömer · Glienicke, DE

Key dates

Filing date	Dec 14, 2012
Grant date	Dec 8, 2015
Priority date	—
Expiry date	Apr 13, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel substituted 5-(1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives having protein tyrosine kinase inhibitory activities, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for treating proliferative disorders, in particular cancer and tumor diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.